|
S100A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78900000369353E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70703999999855E-05 |
| Normal-vs-Stage2 |
1.213000E-01 |
| Normal-vs-Stage3 |
9.70369999999665E-05 |
| Normal-vs-Stage4 |
9.418800E-04 |
| Stage1-vs-Stage2 |
3.718200E-01 |
| Stage1-vs-Stage3 |
3.178800E-01 |
| Stage1-vs-Stage4 |
4.068000E-01 |
| Stage2-vs-Stage3 |
1.624000E-01 |
| Stage2-vs-Stage4 |
1.924200E-01 |
| Stage3-vs-Stage4 |
9.648400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.82459999950891E-07 |
| Normal-vs-AfricanAmerican |
2.405300E-04 |
| Normal-vs-Asian |
3.916000E-01 |
| Caucasian-vs-AfricanAmerican |
3.490000E-02 |
| Caucasian-vs-Asian |
8.309200E-01 |
| AfricanAmerican-vs-Asian |
3.342200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99580000004307E-06 |
| Normal-vs-Female |
4.14490000000267E-06 |
| Male-vs-Female |
3.151000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.572630E-01 |
| Normal-vs-Age(41-60Yrs) |
2.59660000001549E-06 |
| Normal-vs-Age(61-80Yrs) |
2.0857999999957E-05 |
| Normal-vs-Age(81-100Yrs) |
6.367900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.354000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.394000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.307200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.246600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.127400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.453400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.052600E-01 |
| Normal-vs-Grade 2 |
1.895860E-03 |
| Normal-vs-Grade 3 |
1.53270000025074E-07 |
| Normal-vs-Grade 4 |
5.431600E-04 |
| Grade 1-vs-Grade 2 |
7.036200E-01 |
| Grade 1-vs-Grade 3 |
6.167600E-01 |
| Grade 1-vs-Grade 4 |
5.887600E-01 |
| Grade 2-vs-Grade 3 |
1.105630E-02 |
| Grade 2-vs-Grade 4 |
6.082500E-02 |
| Grade 3-vs-Grade 4 |
8.737200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.980800E-03 |
| Normal-vs-ccB subtype |
1.24749999996787E-06 |
| ccA subtype-vs-ccB subtype |
4.831700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.11590000004569E-06 |
| Normal-vs-N1 |
4.561800E-02 |
| N0-vs-N1 |
4.518600E-01 |
|
|
